クリングルファーマ株式会社.

NEWS

お知らせ


Warning: Invalid argument supplied for foreach() in /home/r3716923/public_html/kringle-pharma.com/wp-content/themes/kringle_pharma/view/single/default.php on line 21
2017.12.22

Acute SCI Phase I/II completed PDF

Kringle Pharma announces completion of participant enrollment in the Phase I/II study of recombinant human HGF for acute spinal cord injury.